"Angiotensin II for the Treatment of Vasodilatory Shock" by Ashish Khanna

Selected Works of Kenneth Krell, MD

Follow Contact

Article

Angiotensin II for the Treatment of Vasodilatory Shock

The New England Journal of Medicine (2017)

Ashish Khanna, Cleveland Clinic
Shane W. English, University of Ottawa
Xueyuan S. Wang, Duke University
Kealy Ham, Regions Hospital
James Tumlin, University of Tennessee
Harold Szerlip, Baylor University Medical Center
Laurence W. Busse, Emory University
Laith Altaweel, Inova Medical Center
Timothy E. Albertson, University of California, Davis
Caleb Mackey, University of California, Los Angeles
Michael T. McCurdy, La Jolla Pharmaceutical Company
David W. Boldt, Riverside Methodist Hospital
Stefan Chock, Riverside Methodist Hospital
Paul J. Young, Sunrise Hospital
Kenneth Krell, Eastern Idaho Regional Medical Center
Richard G. Wunderink, Northwestern University
Marlies Ostermann, Guy's and St Thomas' NHS Foundation Trust
Raghavan Murugan, University of Pittsburgh
Michelle N. Gong, Yeshiva University
Rakshit Panwar, University of Newcastle
Johanna Hästbacka, university of lille
Raphael Favory, University of Melbourne
Balasubramanian Venkatesh, University of Melbourne
B. Taylor Thompson, University of Melbourne
Rinaldo Bellomo, University of Melbourne
Jeffrey Jensen, Lille University of Science and Technology
Jeffrey Jensen, University of Helsinki
Stew Kroll, Cleveland Clinic
Lakhmir S. Chawla, University of Ottawa
George F. Tidmarsh, University of Maryland, Baltimore
George F. Tidmarsh, Harvard University
George F. Tidmarsh, Cleveland Clinic
Adam M. Deane, University of Maryland, Baltimore

Link

Disciplines

Publication Date

May 21, 2017

DOI

10.1056/NEJMOA1704154

Citation Information

Ashish Khanna, Shane W. English, Xueyuan S. Wang, Kealy Ham, et al.. "Angiotensin II for the Treatment of Vasodilatory Shock" The New England Journal of Medicine Vol. 377 Iss. 5 (2017) p. 419 - 430
Available at: http://works.bepress.com/kenneth-krell/13/